BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24652347)

  • 1. Altered biodistribution of FDG in patients with type-2 diabetes mellitus.
    Ozguven MA; Karacalioglu AO; Ince S; Emer MO
    Ann Nucl Med; 2014 Jul; 28(6):505-11. PubMed ID: 24652347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin.
    Oh JR; Song HC; Chong A; Ha JM; Jeong SY; Min JJ; Bom HS
    AJR Am J Roentgenol; 2010 Dec; 195(6):1404-10. PubMed ID: 21098202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin-related colonic glucose uptake; potential role for increasing glucose disposal?--A retrospective analysis of (18)F-FDG uptake in the colon on PET-CT.
    Bahler L; Stroek K; Hoekstra JB; Verberne HJ; Holleman F
    Diabetes Res Clin Pract; 2016 Apr; 114():55-63. PubMed ID: 27103370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
    Büsing KA; Schönberg SO; Brade J; Wasser K
    Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
    Roy FN; Beaulieu S; Boucher L; Bourdeau I; Cohade C
    J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High and typical 18F-FDG bowel uptake in patients treated with metformin.
    Gontier E; Fourme E; Wartski M; Blondet C; Bonardel G; Le Stanc E; Mantzarides M; Foehrenbach H; Pecking AP; Alberini JL
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):95-9. PubMed ID: 17786437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging during hypoglycaemia to study adipose tissue metabolism.
    Boss M; Rooijackers HMM; Buitinga M; Janssen MJR; Arens AIJ; de Geus-Oei LF; Salm LP; de Galan BE; Gotthardt M
    Eur J Clin Invest; 2019 Jul; 49(7):e13120. PubMed ID: 31002171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oral contrast on large bowel activity in FDG-PET/CT.
    Otsuka H; Graham MM; Kubo A; Nishitani H
    Ann Nucl Med; 2005 Apr; 19(2):101-8. PubMed ID: 15909489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
    Sun XG; Huang G; Liu JJ; Wan LR
    Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients.
    Turcotte E; Leblanc M; Carpentier A; Bénard F
    Mol Imaging Biol; 2006; 8(6):348-54. PubMed ID: 17053859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Webb RL; Landau E; Klein D; DiPoce J; Volkin D; Belman J; Voutsinas N; Brenner A
    Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.
    Toriihara A; Yoshida K; Umehara I; Shibuya H
    Ann Nucl Med; 2011 Apr; 25(3):173-8. PubMed ID: 21088936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
    Kodama N; Tahara N; Tahara A; Honda A; Nitta Y; Mizoguchi M; Kaida H; Ishibashi M; Abe T; Ikeda H; Narula J; Fukumoto Y; Yamagishi S; Imaizumi T
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4438-45. PubMed ID: 24030946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.